[The highlights of nephrology in 2024]

Kidney involvement in myelodysplastic syndromes

Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis

Bioactive silica nanoparticles target autophagy, NF-κB, and MAPK pathways to inhibit osteoclastogenesis

[Voclosporin for the treatment of lupus nephritis]

Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins

RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis-Novel Targets for Therapy?

Metabolic pathways and immunometabolism in rare kidney diseases

Investigation of a possible extended risk haplotype in the IL23R region associated with ankylosing spondylitis

Urinary Soluble CD163 in Active Renal Vasculitis

The lymphotoxin β receptor is a potential therapeutic target in renal inflammation

[Prognosis and therapy of inflammatory rheumatic diseases : Impact of renal manifestations]

[Vasculitis and the kidney]

[Caplan's syndrome: rarely presenting as <<pulmorenal>> syndrome]

Integrative biology identifies shared transcriptional networks in CKD

A CCR6 variant strongly associated with rheumatoid arthritis in two populations is not associated with ankylosing spondylitis

Human Mendelian pain disorders: a key to discovery and validation of novel analgesics

CALCIFYING TENDINOPATHY: A LOCAL OR A SYSTEMIC CONDITION?

Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis

Intrarenal production of B-cell survival factors in human lupus nephritis

Patients with IgA nephropathy exhibit high systemic PDGF-DD levels

Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice

CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis

Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice

Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy

Ethnic variation in the impact of negative affect and emotion inhibition on the health of older adults

Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion

Acral purpuric plaques in a woman with asthma: a case of allergic granulomatosis angiitis

Chromosome conformation capture approaches to investigate 3D genome architecture in Ankylosing Spondylitis

Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the RUNX3 Promoter

Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis

Perspectives on the Genetic Associations of Ankylosing Spondylitis

The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis

Quantifying the genetic risk for the development of axial spondyloarthropathy: could this become a diagnostic tool?

Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation

The genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression

Evidence of genetic association between TNFRSF1A encoding the p55 tumour necrosis factor receptor, and ankylosing spondylitis in UK Caucasians

B cell Maturation Antigen Targeted Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis

Tumid Lupus Erythematosus Presenting as Patchy Alopecia: A Discussion of Alopecia Associated With Lupus Erythematosus

GDF15 Suppresses Lymphoproliferation and Humoral Autoimmunity in a Murine Model of Systemic Lupus Erythematosus

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland

[Antiphospholipid syndrome, systemic lupus erythematosus: endocarditis and glomerulopathy]

Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus

[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]

Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis

HYLAN G-F 20 VERSUS TRIAMCINOLONE IN THE TREATMENT OF PRIMARY SHOULDER OSTEOARTHRITIS. RANDOMIZED TRIAL

[Antiphospholipid syndrome, systemic lupus erythematosus: endocarditis and glomerulopathy]

[Anti-RNA polymerase III antibodies in scleroderma renal crisis]

18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome

Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome